Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
UCSF Alpha Clinic
Search form
Search...
About Us
Our Team
Steering Committee
Contact Us
Clinical Trials
Research Partners
Training & Education
Research Fellowship
News
Revolutionary Care: An Oakland Story
Upcoming Events
You are here
Home
>
A Phase 1 Clinical Trial of Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
A Phase 1 Clinical Trial of Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Disease Name
:
Non-Hodgkin Lymphoma
Study Status
:
Recruiting
Date
:
July 18, 2024
Detail Link ( on-site link )
:
https://alphaclinic.ucsf.edu/node/9126
Work with the UCSF Alpha Clinic
Request an intake consult